secwatch.observer — SEC 8-K summary
======================================

Issuer:     Minerva Neurosciences, Inc. (NERV)
CIK:        0001598646
Form:       8-K
Filed at:   2022-04-13T23:59:59+00:00
Accession:  0001193125-22-103843
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Minerva Neurosciences hosts roluperidone update webcast; no specific details in 8-K
--------------------------------------------------------------------------------

- Company held an investor webcast on April 13, 2022, to discuss updates on roluperidone.
- The 8-K filing includes only a cover page and dial-in information for the webcast.
- No clinical data, regulatory milestones, or financial guidance were disclosed in the filing.
- Investors must access the webcast replay or presentation to learn the actual update content.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1598646/000119312522103843/0001193125-22-103843-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1598646/000119312522103843/d333769d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-103843

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer